INTI 8-K 2026-09-18

Inhibitor Therapeutics, Inc. (INTI) 8-K dated 2026-09-18 — accession 0001493152-26-043331. This URL is the filing, not the INTI hub.

Inhibitor Therapeutics, Inc. (INTI) is a biotechnology company listed on US.

Inhibitor Therapeutics, Inc. filed a 8-K on 2026-09-18. Accession 0001493152-26-043331.

Cached items: 5.02, 5.07. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported INTI revenue for 2021-12-31 was $0. Net income was -$298.6K. INTI currently screens at market cap $13.3M.

Not investment advice. The INTI SEC hub lists recent forms. The stock page is the research view.